PI
CGEM icon

Putnam Investments’s Cullinan Oncology CGEM Stock Holding History

Putnam Investments’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$226K Buy
+22,210
New +$197K ﹤0.01% 1126

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Putnam Investments's CGEM Position: Q4 2023 in Review

Putnam Investments opened a new position in Cullinan Oncology (CGEM) in Q4 2023: 22,210 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1126 among its holdings.

113 funds tracked by Wall St. Rank hold CGEM as of Q4 2023.

  • Putnam Investments held 22,210 shares of Cullinan Oncology worth $226K as of Q4 2023.
  • Cullinan Oncology was a new Putnam Investments position in Q4 2023.
  • Cullinan Oncology made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1126 holding.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.